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Abstract Our programmatic approach to the Fontan
operation has evolved to include using an extracardiac
conduit with aggressive presumptive treatment of associ-
ated lesions either in the catheterization laboratory or the
operating room. Fenestration is used selectively based on
hemodynamics, anatomy, and presence of associated
lesions. We reviewed our experience to determine the
effectiveness and outcome of this strategy and to assess the
cumulative trauma to the patients. The records of 137
consecutive patients who underwent Fontan at Miami
Children’s Hospital from 1995 to 2008 were reviewed. At
mean follow up of 5.76 years, freedom from death or
transplantation is 94.2% (129/137). Median age at operation
was 4.6 years. Longer length of stay correlated with older
operative age (P = 0.0056). Pacemakers were implanted in
11.7% (16/137). Additional (not pre-Glenn or pre-Fontan)
interventional catheterizations were performed in 51.8%
(71/137). Additional operations were done in 10.2% (14/
137). No patient has required replacement or revision of the
extracardiac conduit. Our current approach to the Fontan
operation provides acceptable midterm results. The pursuit
of residual lesions results in a signiﬁcant number of addi-
tional interventional catheterizations and operative proce-
dures but might have an important inﬂuence on long-term
survival after the Fontan procedure.
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Introduction
Approaches to single ventricle palliation have evolved
since the introduction of the Fontan operation in 1971 [4].
This evolution encompasses multiple technical and ana-
tomic challenges. The technical approach to the Fontan
operation itself has evolved into two major approaches: the
lateral tunnel technique [3] and the extracardiac technique
[9, 12]. Bidirectional cavopulmonary shunt as an interim
staging procedure [7] between initial palliation and Fontan
is now widely used. Fenestration in the Fontan pathway [1]
might reduce the risk of Fontan operation in some patients.
In addition to the technical evolution of the Fontan
procedure, the patients undergoing Fontan operation have
changed. Improved results in single ventricle palliation of
all types and especially of hypoplastic left heart syndrome
have changed the anatomic diagnosis of patients undergo-
ing Fontan procedure, including the increasing proportion
of patients with systemic right ventricles. The 10 Choussat
criteria [2] are rarely present in a modern Fontan patient.
In addition to technical changes in the operation and a
broadening of patients being offered the Fontan procedure,
other important evolutions in cardiac care have occurred. A
signiﬁcant one is the improved ability to intervene on
intracardiac and extracardiac lesions in the cardiac cathe-
terization laboratory [11].
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evolved since 1995. We now perform almost exclusively
extracardiac Fontan procedures using expanded polytetra-
ﬂuoroethylene grafts from the inferior vena cava to the
pulmonary artery–superior vena caval anastomosis. Fen-
estration is performed on a selective basis. Bidirectional
cavopulmonary shunts are performed on all patients who
are initially palliated as babies; some older children who do
not require initial palliation might undergo primary Fontan.
Since 2001, we have programmatically avoided deep
hypothermic circulatory arrest at all stages of single ven-
tricle palliation [5]. Both bidirectional cavopulmonary
anastomosis and Fontan operations are performed with the
heart warm and beating if possible. We aggressively
address associated lesions on a presumptive basis with
treatment either in the cardiac catheterization laboratory or
the operating room.
We retrospectively reviewed our single-institution
Fontan experience from November 1995 to January 2008 to
evaluate the evolution in our approach to the Fontan
operation, the outcome of our approach, and the intensity
of effort and trauma to patients required to achieve these
results.
Materials and Methods
The study was approved by the Western Institutional
Review Board on February 22, 2008, and individual con-
sent was waived. A retrospective study of 137 consecutive
patients who underwent a Fontan procedure at Miami
Children’s Hospital from November 1995 to January 2008
was conducted. All medical records, including surgical and
catheterization records, were reviewed. Cumulative trauma
was deﬁned as all operations, interventions, and hospital-
izations to achieve orthoterminal correction with the
Fontan operation. This included additional chest tubes,
pacemakers, and operations in addition to the usual palli-
ative procedures. It also included interventions in the car-
diac catheterization laboratory, especially those done at a
time separate from preoperative diagnostic catheteriza-
tions. Our current philosophy is to complete the Fontan
operation at around 4 years of age or 15 kg.
Data are given as means with standard deviations or
medians with ranges, as appropriate. Mean values were
compared for Normal distributions using the t-test, and
median values were compared for non-Normal distribu-
tions with the Mann–Whitney rank sum test. The Fisher’s
exact test was used for categorical data. Correlations were
analyzed with the Pearson product moment correlation test.
Survival curves were created using the Kaplan–Meier
method. All analyses were performed with SigmaStat

statistical software (version 3.1; Systat Software, Inc.,
Point Richmond, CA). All P-values less than 0.05 were
considered statistically signiﬁcant.
Results
The Fontan operation was performed at a median age of
4.6 years (range: 1.5–17.0) with a median weight of
16.5 kg (range: 9.4–54). Patients’ diagnoses are summa-
rized in Table 1. For the majority of patients (89.8%), the
Fontan operation consisted of an expanded polytetraﬂuo-
roethylene with external reinforcement (Bard Peripheral
Vascular Inc., Tempe, AZ) extracardiac conduit connecting
the inferior vena cava to the superior vena cava–pulmonary
artery junction. The size of the extracardiac conduit was
either 16 mm (40/123) or 19 mm (81/123); two patients
received 15-mm and 20-mm aortic homografts, respec-
tively. Size was based on the weight of the patient and the
size of the inferior vena cava intraoperatively. There was a
signiﬁcant difference in weight between patients with
16-mm extracardiac conduits and those with 19-mm con-
duits (median: 14.95 kg vs. 17.40 kg; P B 0.001) (Fig. 1).
Fifty percent (69/137) of all patients underwent fenes-
tration and the other half (68/137) were not fenestrated.
The decision to fenestrate was a subjective one, based on
systemic ventricle morphology, pulmonary artery anatomy
and pressures, and the presence or absence of associated
lesions. In general, patients with systemic right ventricles
who had other lesions addressed at the time of the Fontan,
such as aortic arch reconstruction, or who had elevated
pulmonary artery pressures received fenestrations. Fenes-
tration is performed by anastomosing the right atrium at the
superior portion of the right atrial–inferior vena cava suture
line to a 4- or 5-mm punch hole in the conduit. Intracardiac
lateral tunnel Fontan was uncommon (10.2%; 14/137) and
Table 1 Diagnoses of patients who underwent Fontan
Diagnosis n %
HLHS 38 27.7
Tricuspid atresia 35 25.5
TGA 15 10.9
DORV 11 8.0
Unbalanced AVC 7 5.1
PA-IVS 7 5.1
Mitral Atresia 7 5.1
Other
a 17 12.4
AVC atrioventricular canal, DORV double-outlet right ventricle,
HLHS hypoplastic left heart syndrome, PA-IVS pulmonary atresia
with intact ventricular septum, TGA transposition of the great arteries
a Other diagnoses include double inlet ventricle, single ventricle,
tetralogy of Fallot/pulmonary atresia–ventricular septal defect, aortic
stenosis, and tricuspid valve disease/Ebstein’s anomaly
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123was performed more commonly early in the series: Only 1
of the last 113 patients had a lateral tunnel (Fig. 2). The
lateral tunnel technique was done with fenestration.
The majority of patients (94.2%; 129/137) were ﬁrst
staged with a bidirectional cavopulmonary anastomosis,
whereas 5.8% (8/137) underwent primary Fontan, with
both the bidirectional cavopulmonary connection and the
Fontan connection in the same procedure. At the time of
the bidirectional cavopulmonary anastomosis, 24.5%
(27/110) of patients required cardioplegic arrest. This
number excludes patients who had a primary Fontan or
who underwent bidirectional cavopulmonary anastomosis
at another institution. At the time of Fontan, 32.1%
(44/137) required cardioplegia. Of the patients who
underwent extracardiac Fontan, circulatory arrest was used
in 3.3% (4/123) at the time of bidirectional cavopulmonary
anastomosis or Fontan, and cardioplegic arrest was used in
40.7% (50/123).
The median length of stay was 9.0 days (range: 4–76).
Length of stay positively correlated with age at the time of
the Fontan operation (P = 0.0056) (Fig. 3). The length of
stay for patients with fenestrations was signiﬁcantly longer,
compared to those with nonfenestrated Fontans (median
length of stay of 13 days for fenestrated patients vs. 9 days
for nonfenestrated; P = 0.005) (Fig. 3).
Kaplan–Meier survival was 95.6% and 93.6% at 5 and
10 years, respectively, with a mean follow-up of 5.76 years
(Fig. 4). Freedom from mortality and transplantation was
94.2% (129/137).
Catheter Interventions
Of this goup, 62.8% (86/137) underwent a total of 216
catheter interventions, excluding collaterals incidentally
addressed at the time of the usual pre-bidirectional cavo-
pulmonary anastomosis or pre-Fontan catheterization;
51.8% (71/137) required additional interventional cathe-
terizations not coincident with the usual pre-bidirectional
cavopulmonary anastomosis or pre-Fontan catheterizations
(Fig. 5a). The most common catheter intervention was
occlusion of collaterals. Excluding all collateral occlusions,
more patients with fenestrated Fontans required catheter
interventions compared to those without fenestration
(66.7% vs. 45.6%; P = 0.021).
More patients required angioplasty or stenting of the left
pulmonary artery compared to the right pulmonary artery,
Fig. 1 Extracardiac conduit
size versus weight
Fig. 2 Type of Fontan
procedure by date of surgery
Fig. 3 Length of stay (LOS) versus age at time of Fontan
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123both before and after the Fontan procedure (Table 2). The
length of stay was signiﬁcantly longer for those patients
who had pre-Fontan catheter interventions on their left and/
or right pulmonary arteries (median length of stay of
13 days vs. 9 days for those without intervention on their
pulmonary arteries; P = 0.031). Of the patients who
required catheter interventions post-bidirectional cavopul-
monary anastomosis, 14.3% (5/35) underwent the inter-
vention within the same hospitalization. For catheter
interventions post-Fontan, 37.2% (16/43) of patients had
the procedures during the same hospitalization.
Two patients (1.5%) required fenestration creation and
stent placement post-Fontan by catheterization. Three
patients (2.2%) required angioplasty and stenting of their
existing fenestrations. For one patient, the fenestration was
stented. One hybrid procedure was performed to create and
stent a fenestration. Fourteen patients (10.2%) underwent
closure of their fenestrations in the catheterization labora-
tory (Table 2).
Surgical Procedures
A total of 206 surgical interventions were performed in 89
patients (65%). Of these interventions, 14.6% (30/206)
were pulmonary artery plasties at the time of bidirectional
cavopulmonary anastomosis. Aside from the initial pallia-
tion, bidirectional cavopulmonary anastomosis, and Fontan
operation, 14 patients (10.2%) required at least 1 additional
operation (Fig. 5b). No patient has required replacement or
revision of the extracardiac conduit. Three patients had
postoperative surgical fenestration creation or enlargement.
Additionally, 17.5% of patients (24/137) required chest
tubes postoperatively. There was no signiﬁcant difference
in need for chest tubes between fenestrated Fontan proce-
dures and nonfenestrated (P = 0.822).
Sixteen patients (11.7%) required placement of a pace-
maker, and for the majority (12/16), implantation was
during the Fontan operation. Additionally, six patients
had pacing leads placed either concomitantly (n = 5) or
post-Fontan (n = 1). Two patients required ablation of
arrhythmias.
Catheter, surgical, and hybrid interventions are sum-
marized in Tables 3, 4, and 5, respectively. One hundred
seventeen of 137 (85.4%) patients required interventions at
any point, either in the catheterization laboratory or the
operating room. Four patients underwent intraoperative
stent placement in the pulmonary arteries during the Fontan
procedure. Seventy-three of 137 (53.3%) patients required
Fig. 4 Kaplan–Meier survival curve
Fig. 5 Number of patients requiring a interventional catheterizations
in addition to the pre-bidirectional cavopulmonary anastomosis and
pre-Fontan catheterizations, b surgical procedures, in addition to an
initial palliation, bidirectional cavopulmonary anastomosis, and
Fontan, excluding the reinsertion of chest tubes, and c additional
catheterizations or surgeries
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123additional catheterizations or operations beyond initial
palliation, pre-bidirectional cavopulmonary anastomosis
catheterization, bidirectional cavopulmonary anastomosis,
pre-Fontan catheterization, and Fontan procedure (Fig. 5c).
Mortality
There were seven mortalities (5.1%); two were in-hospital
deaths, after undergoing Fontan operation at 6 years and
12 years of age, respectively. One patient died from a
bronchial hemorrhage and the second death was due to
plastic bronchitis. The remaining ﬁve mortalities were after
discharge at a range of 16 days to 6.4 years post-Fontan
operation. One patient died as an outpatient from pericar-
dial effusion. Another suffered from protein-losing enter-
opathy. One patient died after attempted two-ventricle
conversion at another institution. Two patients had neuro-
logical damage prior to death. Two Fontans were taken
down; one of these patients was among the seven mortal-
ities and the other went on to heart transplantation.
Discussion
Our current approach to the Fontan procedure offers
acceptable early mortality and morbidity compared to lit-
erature reports [6, 8, 13]. Postoperative length of stay and
need for reinsertion of chest tubes for postoperative effu-
sions are comparable to literature reports [10, 13]. No
Table 2 Catheter interventions performed pre-Fontan and post-Fontan
Pre-Fontan interventions Post-Fontan interventions
No. of patients % No. of patients %
Collateral occlusion 46 33.6 Collateral occlusion 14 10.2
Aorta 18 13.1 Bilateral PAs
Angioplasty 18 13.1 Angioplasty 2 1.5
Stent 2 1.5 LPA 13 9.5
Stent angioplasty 2 1.5 Angioplasty 1 0.7
Bilateral PAs Stent 12 8.8
Angioplasty 3 2.2 Stent angioplasty 1 0.7
LPA 18 13.1 RPA 7 5.1
Angioplasty 13 9.5 Angioplasty 1 0.7
Stent 9 6.6 Stent 6 4.4
Stent Angioplasty 1 0.7 Fenestration 6 4.4
RPA 6 4.4 Creation 2 1.5
Angioplasty 4 2.9 Angioplasty 3 2.2
Stent 3 2.2 Stent 6 4.4
Stent angioplasty 1 0.7 Fenestration closure 14 10.2
Atrial septostomy 9 6.6
LPA left pulmonary artery, PAs pulmonary arteries, RPA right pulmonary artery
Table 3 Pre-Fontan procedures
Procedure Catheter Surgical Hybrid
Aorta 18 6 1
Pulmonary arteries 24 33 2
Pulmonary valvuloplasty 2 0 0
Atrial septostomy/septectomy 9 18 3
Pacemaker – 3 0
Table 4 Intraoperative procedures during Fontan
Procedure Surgical Hybrid
Aorta 6 0
Tricuspid or mitral valvuloplasty 4 0
Pulmonary arteries 14 4
Atrial septectomy 11 0
Pacemaker 12 0
Table 5 Post-Fontan procedures
Procedure Catheter Surgical Hybrid
Pulmonary arteries 15 0 0
Fontan conduit 5 0 0
Fenestration creation/stenting 6 3 1
Fenestration closure 14 0 0
Pacemaker – 1 0
Tube thoracostomy – 24 0
Fontan takedown – 2 0
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123patient required revision of the extracardiac conduit
because of growth or for other reasons. Four patients
(2.9%) required stenting of the Fontan conduit, and one
patient underwent angioplasty of the conduit.
Our approach to bidirectional cavopulmonary anasto-
mosis and extracardiac Fontan has resulted in an acceptable
rate of pacemaker implantation (11.7%). In addition, at our
relatively short follow-up, arrhythmias requiring ablation
have occurred in only two patients.
The approach to fenestration appears to have been
successful and validated. The need to create a fenestration
postoperatively has been uncommon (5/137; 3.6%). The
length of stay for fenestrated Fontans was signiﬁcantly
longer than nonfenestrated, indicating that we have suc-
cessfully identiﬁed a high-risk group. Signiﬁcantly more
patients with fenestration required catheter interventions
(66.7%), compared to those without fenestration (45.6%;
P = 0.021). However, there was no signiﬁcant difference
for reinsertion of chest tubes, pacemaker implantation, and
mortality between fenestrated and nonfenestrated patients.
Twenty percent of fenestrated patients underwent fenes-
tration closure in the catheterization laboratory.
The technique for fenestration has evolved. We now
sew the anterior portion of the atrial transection directly
to a 4-mm punch hole in the anterior medial surface of
the graft. We have not systematically studied fenestration
patency, but this technique appears to be superior to
others.
Our presumptive approach to treating associated lesions
results in a signiﬁcant number of interventions: 216 in the
catheterization laboratory and 206 in the operating room.
Many of these interventions are, however, associated with
the usual preoperative catheterizations or the operative
procedure itself (Fig. 5). Many of the operative interven-
tions were pulmonary artery angioplasties at the time of
the bidirectional cavopulmonary anastomosis. Additional
catheterizations for intervention were required in 71
patients (51.8%) and additional operations were required in
14 patients (10.2%). Forty-four (32.1%) patients required
only one extra catheter or surgical procedure.
Limitations
Our study is clearly limited by our inability to directly
correlate our approach to associated lesions and our out-
comes. Although we might infer that this part of our
overall Fontan strategy has an important role in our out-
comes, such inference might be incorrect. It might be just
as fruitful to wait until associated lesions have important
consequences before treatment. We ﬁnd this approach
unpalatable, in part, because of the fragility of Fontan
patients with residual lesions in the early postoperative
period.
A signiﬁcant limitation of our study is our limited period
of follow-up and the limitations it imposes on long-term
conclusions. A possible limitation of the extracardiac
Fontan operation is the use of a circumferential artiﬁcial
conduit, potentially requiring reoperation as patients reach
adulthood. We currently have not observed the need for
conduit replacement in any patient.
The Fontan circulation is a life-long disease state with
its own associated lesions. The long-term incidence of
important sequelae, such as arrhythmia and protein-losing
enteropathy, is not addressed in this report. We would
propose, however, that good short-term outcomes might
positively affect long-term outcomes.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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